Picture of Biohit Oyj logo

BIOBV — Biohit Oyj News Story

0.000.00%
fi flag iconLast trade - 00:00
HealthcareAdventurousMicro CapContrarian

Brief: Biohit H2 Operating EBITDA EUR 0.2 Million

Feb 19 (Reuters) - Biohit Oyj  BIOBV.HE :
    * H2 NET SALES EUR 5.1 MILLION VERSUS EUR 5.0 MILLION YEAR AGO
    * H2 OPERATING EBITDA EUR 0.2 MILLION VERSUS EUR 0.0 MILLION YEAR AGO
    * GASTROPANEL NET SALES IN CHINA DECREASED DUE TO DELAY IN RE-REGISTRATION
    * GASTROPANEL DELIVERIES TO CHINA WILL GROW IN 2020 IF LOGISTICS PROBLEMS CREATED BY
CORONAVIRUS
(2019-NCOV) WON'T CONTINUE
    * IN BEGINNING OF 2020 OUR BUSINESS IN CHINA HAS NORMALIZED AND WE ARE ABLE TO DELIVER
GASTROPANEL® PRODUCTS TO CHINA AS PREVIOUSLY
    * EXPECTS ITS 2020 NET SALES GROWING COMPARING 2019 (PREVIOUS YEAR EUR 10.1 MILLION).

Source text for Eikon:  ID:nWkrbVv4GT 
Further company coverage:  BIOBV.HE 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on Biohit Oyj

See all news